TrialJournal of cosmetic dermatology2022

An open-label, investigator-initiated, single-center, prospective, pilot clinical study to evaluate the efficacy of a skin whitening serum applied twice daily combined with a spot-preventing SPF50+ sunscreen in healthy female subjects with melasma hyperpigmentation.

Mariateresa Cantelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.